Effect of Oral Nutritional Supplements to Older Patients Discharged With a Rehabilitation Plan (NUTRIMUSCLE)

May 12, 2026 updated by: Anne Marie Beck, Herlev and Gentofte Hospital

Effect of Oral Nutritional Supplements on Muscle Strength in Older Patients at Nutritional Risk Discharged With a Rehabilitation Plan

The purpose of the study is to investigate whether an extra intake of energy and protein in the form of nutritional drinks twice a day for 12 weeks can improve muscle strength, muscle mass, quality of life and the implementation of rehabilitation in elderly patients at nutritional risk who are discharged to municipal rehabilitation

Study Overview

Detailed Description

The study is a single-blind randomised study where the subjects will be randomly divided into two groups. A group that must consume nutritional drinks in connection with their rehabilitation and a group that must do nothing extra. Based on a statistical power calculation, we will include a total of 124 patients.

In connection with the experiment, different data will be collected three times, in connection with the discharge from the hospital, after 6 weeks via the telephone and after 12 weeks. During a home visit. Here, various questionnaires will have to be answered and data on muscle strength and muscle mass will be collected. Further CRP, vitamin D status and EPA/DHA content in blood will be assessed.

In addition, data is collected from the patient's medical record about e.g. readmissions

Study Type

Interventional

Enrollment (Actual)

123

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Herlev, Denmark, 2730
        • Herlev and Gentofte Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Men and women aged ≥ 65 years old
  • Independent stand function

    • Able to speak and understand Danish
    • At nutritional risk according to NRS-2002
    • (Expected to be) discharged with a new rehabilitation plan
    • Admitted to the medical and orthopaedic departments of Gentofte or Herlev Hospital

Exclusion Criteria:

  • Active cancer

    • Renal insufficiency (eGFR < 27 mL/min/1.73m2)
    • Cognitive impairment (not able to comprehend the purpose of the study/give informed consent)
    • Terminal disease
    • Exclusively receiving texture modified food, enteral or parenteral nutrition
    • Planning to lose weight/go on a special diet
    • Planned transfer to other hospitals/departments
    • Pacemaker/other implanted electrical stimulants (due to Bio-Impedance Analysis (BIA)

      • Taking fish-oil supplements as a medical prescription due to hypertriglyceridemia
      • Taking fish-oil supplements for other reasons and do not wish to stop this during the study period

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Intervention
the intervention group will be provided with oral nutritional supplements for 12 weeks after discharge
An oral supplement with a high content of protein and with essential fatty acids
No Intervention: Control
the control group will receive usual care after discharge

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Leg Muscle strength
Time Frame: change from baseline to 12 weeks follow-up
Chair stand
change from baseline to 12 weeks follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hand grip Muscle strength
Time Frame: change from baseline to 12 weeks follow-up
Hand grip strength
change from baseline to 12 weeks follow-up
energy and protein intake
Time Frame: at 12 weeks follow-up
24 hour dietary recall
at 12 weeks follow-up
Appetite
Time Frame: Change from baseline to 12 week follow-up
Simplified Nutritional Appetite Questionnaire [SNAQ. The questionnaire results in a score ranging from 5 to 20, where 5 is lowest appetite
Change from baseline to 12 week follow-up
Frailty
Time Frame: Change from baseline to 12 weeks follow-up
The "FRAIL" Questionnaire includes questions concerning Fatigue, Resistance (capability of stair climbing),Aerobic( walking distance), Illnesses (multi morbidity), and Loss of weight. Physical frailty, pre-frailty and non-frailty is defined as having 3 or greater; 1 or 2 or no factors respectively
Change from baseline to 12 weeks follow-up
initiation and completion of rehabilitation
Time Frame: at 12 week follow-up
questionnaire were participants can document their attendance to exercise rehabilitation and reasons for not attending.
at 12 week follow-up
compliance to oral nutritional supplements
Time Frame: at 12 weeks follow-up
a diary were participants can register their intake of supplements and eventual side effects. A compliance of 100% is aimed for as optimal
at 12 weeks follow-up
inflammation
Time Frame: change from baseline to 12 weeks follow-up
blood measurements of CRP and omega-3 fatty acids
change from baseline to 12 weeks follow-up
vitamin D status
Time Frame: change from baseline to 12 weeks follow-up
blood measurements of vitamin D
change from baseline to 12 weeks follow-up
Muscle mass
Time Frame: Change from baseline to 12 week follow-up
Calf circumference assessment of muscle mass
Change from baseline to 12 week follow-up
Hydration status
Time Frame: Change from Baseline to 12 weeks follow up
Blood measurements and calculation of serum osmolarity
Change from Baseline to 12 weeks follow up
Health related quality of life
Time Frame: Change from baseline to 6 and 12 weeks follow-up
EQ5D5L questionnaire with five dimensions and five level of answers. To be converted to an index were -1 is worst and 1 is best health related quality of life
Change from baseline to 6 and 12 weeks follow-up
Activities of daily living
Time Frame: Change from baseline to 6 and 12 weeks follow-up
Functional recovery score The eleven-item questionnaire is comprised of three main components: basic activities of daily living (BADL) assessed by four items, instrumental activities of daily living (IADL) assessed by six items, and mobility assessed by one item. Basic activities of daily living comprise 44 percent of the score; instrumental activities of daily living comprise 23 percent, and mobility comprises 33 percent. Complete independence in basic and instrumental activities of daily living and mobility results in a score of 100 percent
Change from baseline to 6 and 12 weeks follow-up
readmissions
Time Frame: 30 days and 38 weeks after discharge
number, length and percentage of readmissions after discharge will be calculated
30 days and 38 weeks after discharge
mortality
Time Frame: 30 days and 38 weeks after discharge
number and percentage of mortality after discharge will be calculated
30 days and 38 weeks after discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: Tina Munk, PhD, Herlev and Gentofte Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2023

Primary Completion (Actual)

September 30, 2025

Study Completion (Actual)

March 30, 2026

Study Registration Dates

First Submitted

September 21, 2022

First Submitted That Met QC Criteria

September 23, 2022

First Posted (Actual)

September 27, 2022

Study Record Updates

Last Update Posted (Actual)

May 14, 2026

Last Update Submitted That Met QC Criteria

May 12, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • version2/30.03.2022

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

No plans yet

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rehabilitation

Clinical Trials on Protein omega-3

Subscribe